ReviewACS synthetic biology2026
Nanofluidics for Pioneering Synthetic Biology of Bottom-Up Cell-Free Molecular Systems.
Review in ACS synthetic biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synthetic biology via bottom-up assembly is transitioning from stochastic, extract-based cell-free systems toward reconstituted, molecularly defined cell-free molecular systems. Transitioning to molecularly defined systems provides a path to quantitative design; however, the active assembly of these molecular building blocks into ordered spatiotemporal architectures remains a formidable challenge in synthetic biology. In this perspective, we propose nanofluidics as a transformative platform to bridge this gap. By leveraging nanoconfinement effects and precision mass transport, nanofluidics facilitates the active assembly of molecular building blocks into functionally integrated spatiotemporal structures, thereby pioneering the synthetic biology of bottom-up cell-free molecular systems. Specifically, we discuss how nanofluidics enables precise control over fluid dynamics and single-molecule behavior within nanochannels and facilitates molecular active-assembly and tunable interactions of molecular components by engineering design of nanofluidic devices. Furthermore, we highlight key challenges and opportunities using nanofluidics to build next-generation cell-free molecular systems with single-molecule resolution. This perspective provides a strategic roadmap for the synthetic biology of bottom-up cell-free molecular systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.